Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a collaboration with Microsoft to build what they refer to as the world’s largest image-based AI models for digital pathology and oncology. Image courtesy: Paige
September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a collaboration with Microsoft to build what they refer to as the world’s largest image-based AI models for digital pathology and oncology. Paige developed the first Large Foundation Model using over one billion images from half a million pathology slides across multiple cancer types, according to a September 7 statement issued by the company. It further reports that Paige is developing a new AI model with Microsoft that is “orders-of-magnitude larger than any other image-based AI model existing today, configured with billions of parameters.”
The model assists in capturing the subtle complexities of cancer and serves as the cornerstone for the next generation of clinical applications and computational biomarkers that push the boundaries of oncology and pathology, noted the announcement. It allows the two companies to join forces in the fight against cancer, as it allows them to make headway in their collaboration to transform cancer diagnosis and patient care.
Paige Founder and Chief Scientist, Thomas Fuchs, Dr.Sc., said this of the collaboration: “Paige technology already goes beyond what is humanly possible today and helps physicians deliver better cancer care with AI support. By realizing the potential of generative AI at unprecedented scale, the Paige model collaboration with Microsoft is a milestone in the history of oncology.”
“By combining Microsoft’s world-class research and cloud infrastructure with Paige’s deep expertise and large-scale data, we are creating new AI models that will enable unprecedented insights into the pathology of cancer,” said Desney Tan, Vice President and Managing Director, Microsoft Health Futures. “Unleashing the power of AI is a game changer in advancing healthcare to improve lives,” Tan added.
In this next phase of development, Paige is incorporating up to four million digitized microscopy slides across multiple types of cancer from its unmatched petabyte-scale archive of clinical data. Paige will utilize Microsoft’s advanced supercomputing infrastructure to train the technology at scale and ultimately deploy it to hospitals and laboratories across the globe using Azure.
“Paige has been at the forefront of innovation since its inception, and by combining Microsoft’s expertise and enormous compute power with Paige’s deep expertise in AI, technology, and digital pathology, we strongly believe we will significantly advance the state-of-the-art in cancer imaging,” said Razik Yousfi, Paige SVP of Technology. He added, “Through the development of this model, we will help improve the lives of the millions of people who are affected by cancer every day.”
Paige reports that it has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Notably, Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The statement also noted that the same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.
More information: www.paige.ai
Related coverage:
Paige Introduces Advanced Integration Capabilities to its AI Digital Pathology Platform
April 25, 2024 
